A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)


The Latest

Filters

Fisher Investments

Ad Alert

Fisher Investments

Unearthing the fees that Fisher charges but doesn’t disclose in some of its TV ads.


Show More